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Oscillation of Angiogenesis and Vascular Dropout in 
Progressive Human Vascular Disease 
When analyzed by VESsel GENeration Analysis (VESGEN) software, vascular 
patterns provide useful integrative read-outs of complex, interacting molecular 
signaling pathways. Using VESGEN, we recently discovered and published our 
innovative, surprising findings that angiogenesis oscillated with vascular dropout 
throughout progression of diabetic retinopathy, a blinding vascular disease. Our 
findings provide a potential paradigm shift in the current prevailing view on progression 
and treatment of this disease, and a new early-stage window of regenerative 
therapeutic opportunities. The findings also suggest that angiogenesis may oscillate 
with vascular disease in a homeostatic-like manner during early stages of other 
inflammatory progressive diseases such as cancer and coronary vascular disease. · 

Recent results with Peter Kaiser MD, Cole Eye Institute 
Oscillation of vessel density with progression of diabetic retinopathy 
"Eye as a Window to the Body" 
True of other vascular-dependent progressive diseases such as 
solid tumors? 
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Mapping and Quantification of Microvascular 
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Mapping of Progressive Diabetic Retinopathy by VESGEN 
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Angiogenesis Oscillates with Vascular Dropout 
during Progression of Diabetic Retinopathy 
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Slight Trend toward Increasing Diameter of Larger Vessels 
during Progression of Diabetic Retinopathy 
II G1-5 II G~6 
A Arterial B Venous 
* 
* ** 
VRS 1 VRS 2 VRS 3 VRS 4 VRS 1 VRS 2 VRS3 VRS4 
Vascular Remodeling Status (VRS) 
Parsons, Radhakrishnan, Vickerman & Kaiser, Investigative Ophthalmology & Visual Science 51 (1 ):498-507 (201 0) 
12 
Oscillation of Angiogenesis with Vascular Dropout: 
Systems Biology Analysis 
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Reviewed in Anatomical Record A 2009; Anatomical Record A 288A:233 (2006) 
22 










with J Sears & Q Ebrahem (Cole Eye Institute), from Vickerman et al, Anatomical Record A 292(3), 2009 
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CORONARY VESSEL NETWORK-TO-TREE TRANSITIONS 
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Vascular Targeting of Tumor Vessels 
In RIP-Tag Transgenic Mice 
by iv Injection 
D lgG injected iv 
*t 
aS integrin antibody injected iv 
* 
T 
D D 0 
Normal islets Small Medium Large 
RIP-Tag2 pancreatic tumors 
Parsons et al, American Journal of Pathology 167(1 ): 193-211 (2005) 
26 
Vascular Targeting: a5~1 lntegrin Antibody iv in Transgenic RIP-Tag2 Pancreatic Tumors 
27 
ogy 167(1 ): 193-211 (2005) 





® 10 min 1 hr 6 hr 24 hr Time after injection 
Parsons et al, American Journal of Pathology 167(1):193-211(2005) 
Vascular Targeting: Increasing Expression of a5~1 lntegrin in Blood Vessels with RIP-Tag2Tumor Progression 
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FRACTAL SCALING of Vascular Network and lntegrin Expression with Tumor Progression 
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Mapping & Quantification 
Integrative Systems Biology: 
'Fingerprint' or 'Signature' Mapping of Dominant Vascular Patterns 
Induced by VEGF and Other Angiogenesis Regulators 
Fractal-Based VESGEN for Multi-Parametric Pattern Analysis according to 
Branching Generation 
Clinical Research Application: Oscillation of Angiogenesis with 
Vascular Dropout in Diabetic Retinopathy 
General paradigm for progression of other diseases such as cancer? 
Integrated Scaling of Vascular Anatomy with Signaling Regulators such 
as a5~1 lntegrin during Tumor Progression 
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Inhibition of Angiogenesis 
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Unique 'Signature' Patterns: 
Vasculature as Integrative Read-Out System of 
Complex Molecular Signaling 
Observation 
Dominant molecular regulators of vascular remodeling and angiogenesis induce 
vascular patterns that are spatia-temporally unique 
Hypothesis as Consequence 
Dominant regulators can be deduced from alterations in vascular pattern 
as integrative read-out of complex molecular and systems signaling 
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Box-Counting Algorithm for Fractal Dimension 
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